{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Schenk S"],"funding":["NICHD NIH HHS","NIDDK NIH HHS","NCRR NIH HHS","NIAMS NIH HHS"],"pagination":["4281-8"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3204844"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["121(11)"],"pubmed_abstract":["Skeletal muscle insulin resistance is a key component of the etiology of type 2 diabetes. Caloric restriction (CR) enhances the sensitivity of skeletal muscle to insulin. However, the molecular signals within skeletal muscle linking CR to improved insulin action remain largely unknown. Recently, the mammalian ortholog of Sir2, sirtuin 1 (Sirt1), has been identified as a potential transducer of perturbations in cellular energy flux into subsequent metabolic adaptations, including modulation of skeletal muscle insulin action. Here, we have demonstrated that CR increases Sirt1 deacetylase activity in skeletal muscle in mice, in parallel with enhanced insulin-stimulated phosphoinositide 3-kinase (PI3K) signaling and glucose uptake. These adaptations in skeletal muscle insulin action were completely abrogated in mice lacking Sirt1 deacetylase activity. Mechanistically, Sirt1 was found to be required for the deacetylation and inactivation of the transcription factor Stat3 during CR, which resulted in decreased gene and protein expression of the p55α/p50α subunits of PI3K, thereby promoting more efficient PI3K signaling during insulin stimulation. Thus, these data demonstrate that Sirt1 is an integral signaling node in skeletal muscle linking CR to improved insulin action, primarily via modulation of PI3K signaling."],"journal":["The Journal of clinical investigation"],"pubmed_title":["Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction."],"pmcid":["PMC3204844"],"funding_grant_id":["R01 DK033651","T32 DK007494","R24 HD050837","R37 DK033651","P01 DK074868","K12 HD057022","U54 HD012303","P30 AR058878","U54 HD012303-25","UL1 RR024146","P30 DK063491","DK063491","DK033651","P30 AR058878-02","DK074868"],"pubmed_authors":["Philp A","Bandyopadhyay GK","Olefsky JM","Chen MZ","McCurdy CE","Schenk S","Holliday MJ","Osborn O","Baar K"],"additional_accession":[]},"is_claimable":false,"name":"Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction.","description":"Skeletal muscle insulin resistance is a key component of the etiology of type 2 diabetes. Caloric restriction (CR) enhances the sensitivity of skeletal muscle to insulin. However, the molecular signals within skeletal muscle linking CR to improved insulin action remain largely unknown. Recently, the mammalian ortholog of Sir2, sirtuin 1 (Sirt1), has been identified as a potential transducer of perturbations in cellular energy flux into subsequent metabolic adaptations, including modulation of skeletal muscle insulin action. Here, we have demonstrated that CR increases Sirt1 deacetylase activity in skeletal muscle in mice, in parallel with enhanced insulin-stimulated phosphoinositide 3-kinase (PI3K) signaling and glucose uptake. These adaptations in skeletal muscle insulin action were completely abrogated in mice lacking Sirt1 deacetylase activity. Mechanistically, Sirt1 was found to be required for the deacetylation and inactivation of the transcription factor Stat3 during CR, which resulted in decreased gene and protein expression of the p55α/p50α subunits of PI3K, thereby promoting more efficient PI3K signaling during insulin stimulation. Thus, these data demonstrate that Sirt1 is an integral signaling node in skeletal muscle linking CR to improved insulin action, primarily via modulation of PI3K signaling.","dates":{"release":"2011-01-01T00:00:00Z","publication":"2011 Nov","modification":"2025-04-04T07:25:31.493Z","creation":"2019-03-27T00:45:31Z"},"accession":"S-EPMC3204844","cross_references":{"pubmed":["21985785"],"doi":["10.1172/jci58554","10.1172/JCI58554"]}}